Clear all filters Results are currently filtered by:
28 July 2017
Real-time Prescription Monitoring to include more prescription pills and training for pharmacists
7 July 2017
In every State and Territory, the pharmacy ownership rules prohibit anyone other than a registered pharmacist from owning a community pharmacy.While the laws differ slightly between jurisdictions, their intent is the same. Lawmakers around Australia have made clear that pharmacists…
5 July 2017
Nearly two weeks on from the release of the Interim Report of the Pharmacy Remuneration and Regulation Review and after being briefed by the Panel, the Guild remains very concerned about the Review's true intentions for the future of community…
5 July 2017
The Pharmacy Guild and the Department of Health have reached agreement on final changes to 6CPA programs agreed to in the Pharmacy Compact.
9 June 2017
The Guild is now focused on the transition to prescription-only codeine products from February next year – with an emphasis on advocacy for an alternative way to keep these medicines available through community pharmacy, patient education, and pharmacy business responses.
7 June 2017
Looming up-scheduling of codeine products an issue of utmost priority for the Guild.
24 May 2017
In this guest editorial, the Hon Greg Hunt MP, Minister for Health, provides an update on the agreement the Government has reached with the Pharmacy Guild as part of the 2017-18 Budget.
19 May 2017
Members are vitally interested in the funding from the $600 million for DAAs, Staged Supply, MedsChecks and Diabetes MedsChecks, and HMR follow-ups in community pharmacy. We must now ensure that the full benefits of this package are delivered to community…
12 May 2017
At the end of a busy Budget week, I want to take this opportunity to convey a few more details to Members about some of the positive measures for pharmacy that were announced on Tuesday night.
10 May 2017
Members of the Medicines Partnership of Australia (MPA), the nation’s pharmaceutical supply chain peak body, have welcomed key initiatives toward stability and ongoing support for the pharmaceutical sector announced as part of this year’s Federal Budget.